Boston-based start-up OM1 has raised $21m in a series B funding round led by Polaris Partners, bringing its total financial backing to $36m. The company is developing an app that will allow users to share their location with friends and family via the internet. The company has already developed the OMView RA system, which offers access to comparative treatment outcomes in rheumatoid arthritis for all major biologics and biosimilars.
Boston-based start-up OM1 has raised $21m in a series B funding round led by Polaris Partners, bringing its total financial backing to $36m. OM1 will use the cash injection to build out its artificial intelligence platform, which "analyses, synthesises and leverages" big clinical data to help improve patient outcomes. The company has already developed the OMView RA system, which offers access to comparative treatment outcomes in rheumatoid arthritis for all major biologics and biosimilars.